References
- 1. ***Global Inititiative for Asthma. Global strategy for asthma management and prevention 2014. Available fromhttp://www.ginasthma.org
- 2. Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech, 2003;4:425-433.
- 3. Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med, 2005;172:1497-1504.
- 4. Saini D, Biris AS, Srirama PK, Mazumder MK. Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers. Pharm Dev Technol, 2007;12:35-41.
- 5. Zanen P, Go LT, Lammers JW. Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction. Thorax, 1996 Oct;51:977-80.
- 6. Usmani OS, Biddiscombe MF, Nightingale JA, Underwood SR, Barnes PJ. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol, 2003;95:2106-2112.
- 7. Zaninudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurized metered dose inhaler, as a dry powder inhaler and as a nebulised solution. Thorax, 1990;45:469-473.
- 8. Sárkány Z, Horvath A, Balashazy I, Hofmann W, Brinzaniuc K, Sabau M. Evaluation of inhaled drug deposition during an asthma attack using a stochastic lung model. Acta Medica Transilvanica, 2013;2:238-240.
- 9. Dolovich M. Influence of inspiratory flow rate, particle size, and airway calibre on aerosolised drug delivery to the lung. Respir Care, 2000;45:597-608.
- 10. Sárkány Z. Morfometria căilor respiratorii inferioare, utilitate în studii de modelare. PhD thesis, University of Medicine and Pharmacy of Târgu Mureș, Romania, 2013, pp. 75-80
- 11. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. International Archives ofOccupational and EnvironmentalHealth, 2001;74:1-8.
- 12. Oberdorster G, Gelein RM, Ferin J, Weiss B. Associationof particulate air pollution and acute mortality: involvementof ultrafine particles? Inhalation Toxicology, 1995; 7:111-124.
- 13. Oberdorster G, Maynard A, Donaldson K, et al. Principlesfor characterizing the potential human health effects fromexposure to nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology, 2005; 2, article 8.
- 14. Pedata P, Garzillo EM, Sannolo N. Ultrafine particlesand effects on the organism: literature review. GiornaleItaliano di Medicina del Lavoro ed Ergonomia, 2010;32:23-31.
- 15. Park SK, O’Neill MS, Vokonas PS, Sparrow D, Schwartz J. Effects of air pollution on heart rate variability: theVA normative aging study. Environmental Health Perspectives, 2005;113:304-309.
- 16. Frampton MW, Utell MJ, Zareba W, et al. Effects ofexposure to ultrafine carbon particles in healthy subjects andsubjects with asthma. Research Report, 2004;126:1-47.
- 17. Evans KA, Halterman JS, Hopke PK, Fagnano M, Rich DQ. Increased ultrafine particles and carbon monoxide concentrations are associated with asthma exacerbation among urban children. Environ Res, 2014;129:11-19.
- 18. Olvera HA, Perez D, Clague JW, et al. The Effect of Ventilation, Age, and AsthmaticCondition on Ultrafine Particle Deposition in Children. Pulmonary Medicine, vol. 2012, Article ID 736290, 9 pages, 2012. doi:10.1155/2012/736290
- 19. Crampton M1, Kinnersley R, Ayres J. Sub-micrometer particle production by pressurized metered dose inhalers. J Aerosol Med, 2004 Spring;17:33-42.
- 20. Faiyazuddin M, Mujahid M, Hussain T, et al. Aerodynamics and deposition effects of inhaled submicron drug aerosol in airway diseases. Recent Pat Inflamm Allergy Drug Discov, 2013;7:49-61.